Antibiotic therapy - Biotech, Pharma and Life Science Channel

18:16 EST 30th January 2015 | BioPortfolio

PubMed Articles [10222 Associated PubMed Articles listed on BioPortfolio]

O(6)-methylguanine-DNA methyltransferase activity is associated with response to alkylating agent therapy and with MGMT promoter methylation in glioblastoma and anaplastic glioma.

CpG methylation in the O(6)-methylguanine-DNA methyltransferase (MGMT) promoter is associated with better outcome following alkylating agent chemotherapy in glioblastoma (GBM) and anaplastic glioma (A...

Combination of low level light therapy and nitrosyl-cobinamide accelerates wound healing.

Effects of tissue water content on the propagation of laser light during low-level laser therapy.

In-vitro Characterization and Evaluation of Apoptotic Potential of Bicistronic Plasmid Encoding HN Gene of Newcastle Disease Virus and Human TNF-α

The viral gene oncotherapy in combination with cytokines emerges as an exciting strategy for cancer therapy due to its minimal side effects and tumor specificity. HN is the surface protein of NDV whic...

Conversation focused aphasia therapy: investigating the adoption of strategies by people with agrammatism.

Background: A recent review of interaction (or conversation)-focused therapy highlighted the potential of programmes targeting the person with aphasia (PWA) directly. However, it noted the key limitat...

Treatment of High-Risk T-NHL with Stem Cell Transplantation: A Single Center Experience.

Prognosis of peripheral and other advanced T cell lymphomas is poor. 20 patients with a median age of 46.4 (range 20.5-64.1) years were treated with autoSCT (n = 6) or alloSCT (n = 14) from 1996 t...

Use of penicillin and streptomycin to reduce spread of bacterial coldwater disease I: antibiotics in sperm extenders.

Abstract Bacterial coldwater disease caused by Flavobacterium psychrophilum has led to the loss of significant numbers of hatchery-reared salmonids. The bacteria can be spread from parent to progeny w...

Vulvodynia.

Vulvodynia is a genital pain syndrome occurring in 7% to 8% of women. Although common, most practitioners are uncomfortable with the diagnosis and management of these women's pain, and many believe th...

Circulating serum levels of IL-20 in multiple myeloma patients: its significance in angiogenesis and disease activity.

Angiogenesis is an important hallmark in multiple myeloma (MM) pathogenesis, with the participation of various versatile molecules. Interleukin-20 (IL-20) is a pro-inflammatory cytokine with diverse a...

Determination of tetracycline hydrochloride by terahertz spectroscopy with PLSR model.

Antibiotic residues in agricultural and food products are of great concern to legislatures and consumers. Reliable techniques for rapid and sensitive detection of these residues are necessary to ensur...

News Articles [5922 Associated News Articles listed on BioPortfolio]

Gene-therapy company Spark Therapeutics shares double in debut

Jan 30 (Reuters) - Shares of Spark Therapeutics Inc more than doubled in their debut, valuing the gene-therapy company at nearly $1.5 billion and underscoring investor's interest in the field that rec...

Barrow Doctors Receive $100,000 to Aid Domestic Violence Victims With Traumatic Brain Injuries

PHOENIX, Jan. 30, 2015 /PRNewswire/ -- Barrow Neurological Institute in Phoenix on Thursday received a $100,000 grant to expand its pioneering treatment program for traumatic brain injuries in do...

Latest Device for In-Home Hair Restoration Technology Cleared by FDA

Leonard Hair Transplant Associates Exclusively Offers Capillus272™ in New England Dr. Robert Leonard, Founder and Chief Surgeon of Leonard Hair Transplant Associates ...

J&J leukaemia drug gets FDA go-ahead

The US Food and Drug Administration has shown Janssen’s leukaemia drug Imbruvica the green light to treat patients with waldenström’s macroglobulinemia (WM) – a rare indolent type of B-cell lym...

FDA Approves Janssen's B-Cell Lymphoma Treatment

Janssen Biotech Inc. (“Janssen”) announced that the U.S. Food and Drug Administration (FDA) has approved imbruvica (ibrutinib) capsules as the first therapy indicated specifically for patients wit...

Gordie Howe’s Stem Cell Therapy Raises Concerns among Regenerative Medicine Experts

(The Vancouver Sun) – Gordie Howe’s son says the hockey legend’s stroke symptoms have improved since his treatment with stem cells at a Mexican clinic in early December and he wants ...

CHOP Invited to White House for President's Announcement of the Precision Medicine Initiative

PHILADELPHIA, Jan. 30, 2015 /PRNewswire-USNewswire/ -- At the invitation of the White House, The Children's Hospital of Philadelphia (CHOP) sent two special guests to President Barack Obama's announce...

Spain uses stem cell therapy to treat damaged hearts

A Spanish hospital has successfully used stem cells culled from healthy donors to treat seven heart attack victims, in what officials said was a world first.

Intercept gets FDA breakthrough therapy status for Obeticholic acid to treat NASH with liver fibrosis

Intercept Pharmaceuticals, announced that its investigational product obeticholic acid (OCA) has received "breakthrough therapy designation" from the U.S. Food and Drug Administration (FDA) for the tr...

What to Do About Pediatric Stroke Remains Elusive

The Thrombolysis in Pediatric Stroke (TIPS) study aimed to resolve whether thrombolytic therapy could be safe and feasible in children presenting with acute ischemic stroke. Unfortunately, the Nationa...

Events [0 Results]

None

Companies [280 Associated Companies listed on BioPortfolio]

Voisin Consulting Life Sciences

Voisin Consulting assists biotechnology, pharmaceutical and biomedical companies in the design and implementation of innovative regulatory strategies to expedite product development programs such as d...

NovoCure

Novocure is a private Jersey Isle oncology company pioneering a novel therapy for solid tumors called TTFields. Novocure US operations are based in Portsmouth, NH and New York, NY...

Hygea Holdings Corp.

Hygea is a diversified healthcare holding company led by a team of nationally recognized industry leaders with backgrounds in insurance, finance, medicine, and technology. The com...

Prima-Temp

Prima-Temp brings new, innovative approaches to many of today’s healthcare challenges through the application of 21st century thermometry. Prima-Temp’s continuous temper...

Cell Therapy Catapult

The Cell Therapy Catapult is a centre of translational excellence for cell therapy and regenerative medicine. Its vision is for the UK to be a global leader in the development, de...

Select Medical Corporation

Co-founded by the father–and–son team of Rocco and Robert Ortenzio in 1996, Select Medical has become one of the nation's largest providers of specialized acute and post...

Eckert & Ziegler AG

Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700), with more than 700 employees, is one of the world’s largest providers of isotope technology for radiatio...

Dimension Therapeutics, Inc.

Dimension Therapeutics, Inc. is a gene therapy company focused on developing novel treatments for patients with hemophilia and rare diseases. Dimension has built a product develop...

BioMonde, LLC

Since 1994 BioMonde have manufactured and supplied Larval Therapy in Europe and the UK. BioMonde are the sole producers of ‘BioBag,’ which provides clinicians and patien...

The Vaccine & Gene Therapy Institute of Florida

Clinical Trials [1088 Associated Clinical Trials listed on BioPortfolio]

Multi-Beam Intensity-Modulated Radiation Therapy for Node-Positive Breast Cancer

This study is being performed to understand the safety of a new radiation treatment called "Multi-Beam Intensity Modulated Radiation Therapy" ( IMRT). Currently, the standard way of giving...

Laser Therapy for the Management of Radiation Dermatitis

Low Level Laser Therapy (LLLT) is a form of phototherapy which involves the application of light to injuries and lesions to promote tissue regeneration. It is a noninvasive treatment modal...

REPEAT Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Therapy in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Who Did Not Respond to Previous PegIntron (Peginterferon Alfa-2b (12KD))/Ribavirin Combination Ther

This 4 arm study is designed for patients with CHC who have not responded to peg interferon alfa-2b (12KD)/ribavirin combination therapy. In these patients, the effects of lengthening the ...

Enhancing Delivery of Problem Solving Therapy Using SmartPhone Technology

This project will be the first to evaluate the Moving Forward app in VA. Identifying an effective treatment for anxiety and depression in primary care is imperative within VHA as they are ...

Minocycline Study in Non Small Cell Lung Cancer (NSCLC) Patients for Chemoradiation Therapy

The goal of this clinical research study is to learn if minocycline can reduce the side effects reported by patients with NSCLC who are receiving chemoradiation therapy. In this study, mi...

Radiation Therapy and Intratumoral Autologous Dendritic Cells in Soft Tissue Sarcomas (STS)

The purpose of this study is to determine if injection of the participant's our own immune related white blood cells (called dendritic cells) into their tumor will strengthen their immune ...

Project CLEAR - Changing Lives by Eradicating Antibiotic Resistance

This randomized controlled trial will compare strategies to reduce the risk of methicillin-resistant Staphylococcus aureus (MRSA) infection and re-hospitalization in MRSA carriers. This tr...

Comparative Study of Ertapenem Versus Another Antibiotic in the Treatment of Diabetic Foot Infections in Adults (0826-034)

This study will compare the efficacy, safety and tolerability of intravenous ertapenem versus another intravenous antibiotic in the treatment of moderate to severe diabetic foot infection...

Evaluation of Skin, Colonic, and Oral Microbiome and Effect of Time and Antibiotic Treatment on Organism Diversity at Each Site

Background: - Most studies of infectious agents have focused on specific microbes, such as human papillomaviruses and cervical cancer, and the hepatitis B and C virus and liver ca...

Cisplatin and Radiation Therapy With or Without Triapine in Treating Patients With Previously Untreated Stage IB-IVA Cervical Cancer or Stage II-IVA Vaginal Cancer

This randomized phase II trial studies how well cisplatin and radiation therapy with or without triapine work in treating patients with previously untreated stage IB-IVA cervical cancer or...

Medical and Biotech [MESH] Definitions

A beta-lactamase inhibitor with very weak antibacterial action. The compound prevents antibiotic destruction of beta-lactam antibiotics by inhibiting beta-lactamases, thus extending their spectrum activity. Combinations of sulbactam with beta-lactam antibiotics have been used successfully for the therapy of infections caused by organisms resistant to the antibiotic alone.

Preliminary cancer therapy (chemotherapy, radiation therapy, hormone/endocrine therapy, immunotherapy, hyperthermia, etc.) that precedes a necessary second modality of treatment.

The presence of fungi circulating in the blood. Opportunistic fungal sepsis is seen most often in immunosuppressed patients with severe neutropenia or in postoperative patients with intravenous catheters and usually follows prolonged antibiotic therapy.

A common inhabitant of the colon flora in human infants and sometimes in adults. It produces a toxin that causes pseudomembranous enterocolitis (ENTEROCOLITIS, PSEUDOMEMBRANOUS) in patients receiving antibiotic therapy.

A therapeutic approach, involving chemotherapy, radiation therapy, or surgery, after initial regimens have failed to lead to improvement in a patient's condition. Salvage therapy is most often used for neoplastic diseases.

Search BioPortfolio:
Loading
Advertisement
Advertisement
review and buy Antibiotic therapy market research data and corporate reports here

Channels Quicklinks